Audited by PwC

Balance sheet - the Novozymes Group

Note Dec. 31, 2012 Dec. 31, 2011
      DKK million DKK million  
ASSETS
11 Intangible assets 2,672  2,221 
13 Property, plant and equipment 7,084  6,557 
14 Deferred tax assets 224  275 
27 Investment in associate 52    -
15 Other receivables   191    -
Non-current assets, total 10,223  9,053 
16 Inventories 1,808  1,741 
17 Trade receivables 2,080  1,971 
18 Tax receivables 138  167 
15 Other receivables 284  195 
Other financial assets 45  48 
Cash at bank and in hand   535  667   
Current assets, total 4,890  4,789 
Assets, total   15,113  13,842   
           
LIABILITIES AND SHAREHOLDERS' EQUITY
19 Common stock 650  650 
Other reserves 432  465 
Retained earnings 8,473  7,694 
Minority interests   13  15   
Shareholders' equity, total 9,568  8,824 
14 Deferred tax liabilities 1,036  905 
20 Provisions 140  152 
21 Other financial liabilities   1,749  1,604   
Non-current liabilities, total 2,925  2,661 
20 Provisions 90  98 
21 Other financial liabilities 286  258 
Trade payables 1,044  745 
18 Tax payables 76  37 
22 Other payables   1,124  1,219   
Current liabilities, total 2,620  2,357 
         
Liabilities, total 5,545  5,018 
Liabilities and shareholders' equity, total 15,113  13,842   
To the top